Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Big-box chain Target is partnering with Kaiser Permanente in southern California to operate four clinics open to all customers, regardless of insurance.
Partners and EMC Corp. are joining forces on what they call The Partners Data Lake, a data and analytics platform that will accelerate clinical research, improve care delivery and reduce costs, reports Clinical Innovation + Technology.
Martin Salia, MD, a surgeon who contracted Ebola while working in Sierra Leone, died on Monday in a biocontainment center in Omaha, reports The New York Times.
Do patients have a responsibility when they fail to follow-up with their physicians? Barron H. Lerner, MD, and professor of medicine and population health at NYU School of Medicine, explores this hazy ethical area in a New York Times editorial.
eHealth Initiative announced its 2020 Roadmap project that brings together stakeholders across the healthcare sector and commit to resolving the biggest challenges facing the industry such as interoperability, value-based care, data access and patient privacy.
The College of Healthcare Information Management Executives has honored Salt Lake City-based Intermountain Healthcare and its vendor partner, VMWare, for a successful collaboration that allowed clinicians to use their own mobile devices while safeguarding patient information.
Data from EHRs and human resources databases can gauge individual nurse performance levels in the areas of care delivery and patient outcomes, according to a study published in Health Services Research.
The federal Health IT Policy Committee has continued its efforts to establish a 10-year interoperability with its meetings focusing on draft recommendations.
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.
